These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 18426663)
1. [Effects of IL-21 alone or in combination with IL-15/IL-2 on proliferation and anti-tumor activity of G-CSF-mobilized peripheral blood mononuclear cells in vitro]. Li L; Liu TQ; Liu ZQ; Liu GX; Ai HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):350-4. PubMed ID: 18426663 [TBL] [Abstract][Full Text] [Related]
2. [Expansion and cytokine secretion profile of human valpha24(+) NKT cells from different sources]. Zhai WH; Huang Y; Wang M; Zhou Z; Zhai WJ; Zhang RL; Zhang P; Han MZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):633-6. PubMed ID: 19549378 [TBL] [Abstract][Full Text] [Related]
3. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion. Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013 [TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin 21 and/or interleukin 12 on the antitumor activity of peripheral blood mononuclear cells in patients with endometrial cancer. Tian YJ; Cui BX; Ma DX; Zhang Y; Hou F; Zhang WJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):292-8. PubMed ID: 21718613 [TBL] [Abstract][Full Text] [Related]
5. [Effects of mobilization with medium dose of rhG-CSF on the immunocyte component of peripheral blood in donors]. Huang WR; Da WM; Deng XL; Gao CJ; Han XP; Wu XX; Li HH; Zhu HY; Jin HJ; Jing Y; Wang SH; Bo J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):852-6. PubMed ID: 16277857 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy. Meehan KR; Wu A; Hassan R; Miao Y; Chawla J; Slack R; Gehan E; Herscowitz HB J Hematother Stem Cell Res; 2001 Apr; 10(2):283-90. PubMed ID: 11359675 [TBL] [Abstract][Full Text] [Related]
7. [Anti-leukemia activity of T cells impacted by dendritic cells added with sodium selenite]. Yang L; Liu FQ; Wang JW; Wu YP; Ding J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):892-7. PubMed ID: 18718085 [TBL] [Abstract][Full Text] [Related]
8. [The Antitumor Activity of G-CSF-Mobilized Peripheral Blood Mononuclear Cells Activated by IL-2 Alone or in Combination with IL-12]. Sun WJ; Guo ZK; Ai HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Dec; 9(4):333-337. PubMed ID: 12578574 [TBL] [Abstract][Full Text] [Related]
9. [Activation ability of CpG ODNs 2216 on PBMNCs from leukemia patients in remission and killing effect of activated PBMNCs on K562 cells]. Gu YY; Chen JH; Ouyang J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):874-8. PubMed ID: 19698220 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells. Li S; Zhou B; Han ZC Thromb Haemost; 2006 Feb; 95(2):301-11. PubMed ID: 16493493 [TBL] [Abstract][Full Text] [Related]
11. [Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro]. Liu JQ; Zhu Y; Chen FX; Zhang NZ; Lv XT; Zhou ZH; Zhang J; Zhang S; Tao ZZ; Li Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):367-70. PubMed ID: 22482405 [TBL] [Abstract][Full Text] [Related]
12. [Effect of various combinations of IL2, IL12 and IL15 on function of human peripheral blood derived NK cells]. Li XH; Ma J; Wu XX; Li M; Wang FF; DA WM; Yu L; Gao CJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):918-23. PubMed ID: 19698229 [TBL] [Abstract][Full Text] [Related]
13. [Ex vivo expansion of highly purified NK cells from human peripheral blood]. Li XH; Ma J; Wang FF; Dou LP; Li M; Gao CJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):373-7. PubMed ID: 17493350 [TBL] [Abstract][Full Text] [Related]
14. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors. Lovgren TR; Tarantolo SR; Evans C; Kuszynski CA; Joshi SS In Vivo; 2002; 16(6):541-50. PubMed ID: 12494899 [TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony stimulation factor (G-CSF) suppresses interleukin (IL)-12 and/or IL-2 induced interferon (IFN)-gamma production and cytotoxicity of decidual mononuclear cells. Sugita K; Hayakawa S; Karasaki-Suzuki M; Hagiwara H; Chishima F; Aleemuzaman S; Li JA; Nishinarita S; Yamamoto T Am J Reprod Immunol; 2003 Jul; 50(1):83-9. PubMed ID: 14506932 [TBL] [Abstract][Full Text] [Related]
16. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice. Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641 [TBL] [Abstract][Full Text] [Related]
17. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21. Ciszewski C; Discepolo V; Pacis A; Doerr N; Tastet O; Mayassi T; Maglio M; Basheer A; Al-Mawsawi LQ; Green PHR; Auricchio R; Troncone R; Waldmann TA; Azimi N; Tagaya Y; Barreiro LB; Jabri B Gastroenterology; 2020 Feb; 158(3):625-637.e13. PubMed ID: 31622625 [TBL] [Abstract][Full Text] [Related]
18. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood]. Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283 [TBL] [Abstract][Full Text] [Related]
19. [Impact of mobilization with rhG-CSF on the proliferation and cytotoxicity of donor's T cells]. Huang WR; Wang LS; Gao CJ; Lu ZZ; Wang H; Duan HF; Da WM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):995-8. PubMed ID: 17096905 [TBL] [Abstract][Full Text] [Related]
20. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2. Vallera DA; Taylor PA; Aukerman SL; Blazar BR Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]